Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, CZ-50005 Hradec Kralove, Czech Republic.
Auton Neurosci. 2011 Jan 20;159(1-2):26-31. doi: 10.1016/j.autneu.2010.07.008. Epub 2010 Aug 3.
The aim of the present study was to investigate the relaxatory function of adenosine receptor subtypes in rat urinary bladder, and if it is altered in the state of inflammation. The in vitro responses to the P1 receptor agonist adenosine were investigated in the presence of the general P2 receptor antagonist pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid (PPADS; 110(-4)M). Experiments were performed on preparations from normal (healthy) rats and rats with cyclophosphamide (CYP; 100mg kg(-1) i. p.)-induced cystitis. The specific P1A(1) antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX; 110(-5)M) decreased the adenosine relaxatory response in normal bladders (-60%), but not in preparations from CYP pre-treated rats. Immunohistochemical findings support the hypothesis that the expression of P1A(1) receptors in the rat urinary bladder is decreased during cystitis. The adenosine-evoked relaxation was not affected by the specific P1A(2A) antagonist SCH 58261 (310(-7)M), neither in normal nor in CYP pre-treated rats. The relaxation to adenosine was, however, significantly increased by the specific P1A(3) antagonist MRS 1523 (110(-5)M) in preparations from both normal and CYP pre-treated rats, suggesting P1A(3) to be mediating bladder contraction. Thus, in the rat urinary bladder the relaxation to adenosine is mainly due to the P1A(1) receptor, while the P1A(3) receptor seems to be responsible for contractile responses. The DPCPX-resistant part of the relaxation is possibly due to the P1A(2B) receptor, the fourth subtype of the adenosine receptor family.
本研究旨在探讨腺苷受体亚型在大鼠膀胱中的松弛功能,以及在炎症状态下是否发生改变。在存在通用 P2 受体拮抗剂吡哆醛-6-偶氮苯-2',4'-二磺酸(PPADS;110(-4)M)的情况下,研究了 P1 受体激动剂腺苷的体外反应。在正常(健康)大鼠和环磷酰胺(CYP;100mg kg(-1) i. p.)诱导膀胱炎大鼠的制剂上进行了实验。特异性 P1A(1)拮抗剂 1,3-二丙基-8-环戊基黄嘌呤(DPCPX;110(-5)M)使正常膀胱中的腺苷松弛反应减少(-60%),但在 CYP 预处理大鼠的制剂中则不然。免疫组织化学发现支持这样的假说,即在膀胱炎期间,大鼠膀胱中 P1A(1)受体的表达减少。在正常和 CYP 预处理大鼠中,特异性 P1A(2A)拮抗剂 SCH 58261(310(-7)M)对腺苷诱导的松弛均无影响。然而,特异性 P1A(3)拮抗剂 MRS 1523(110(-5)M)使正常和 CYP 预处理大鼠的制剂中腺苷诱导的松弛显著增加,表明 P1A(3)介导膀胱收缩。因此,在大鼠膀胱中,腺苷的松弛主要归因于 P1A(1)受体,而 P1A(3)受体似乎负责收缩反应。DPCPX 抗性部分的松弛可能归因于腺苷受体家族的第四种亚型 P1A(2B)受体。